CA-WILSHIRE
Wilshire, a leading global financial services firm, today launched Wilshire Indexes, a new operating entity that will hold its indexing business and focus on expanding adoption of the FT Wilshire index franchise worldwide. Joining Wilshire in the new venture are the Financial Times (FT) and Singapore Exchange (SGX Group) – strategic partners who will help to grow Wilshire’s index business in North America, Europe and Asia.
The Financial Times is committed to promoting the FT Wilshire indexes to its readership and online subscribers worldwide, providing investment professionals and thought leaders with new insights into drivers of market performance. SGX, a leading international multi asset exchange and derivatives hub in Asia, will collaborate with Wilshire Indexes in the provision of indexing solutions and services for institutional investors and intermediaries around the world.
Wilshire Indexes will operate as an independent and separate entity alongside Wilshire’s core investment management and consulting, OCIO, alternatives and analytics businesses, which will continue to be known as Wilshire and operate unchanged. Mark Makepeace, who has served as Wilshire’s Chief Executive Officer, will serve as CEO of Wilshire Indexes.
Andy Stewart, Wilshire’s Deputy Chief Executive Officer, will serve as CEO of Wilshire and Jason Schwarz will serve as Wilshire’s Deputy CEO in addition to his current role as Wilshire’s President.
There continues to be growing demand for indexes to support investment worldwide. Over the past two years, Wilshire’s index platform has been modernized and the architecture rebuilt on new technology to enable its index business to scale rapidly and meet clients’ evolving index needs.
Mark Makepeace, CEO, Wilshire Indexes, said, “Since 2021, we have successfully transformed Wilshire’s legacy index business into a modern index provider. Now, at a pivotal inflection point, this organizational change and outside capital will allow us to focus on our growth plans. We believe that, with the support of our new investors and shareholders, the newly created subsidiary will become an important player in the industry.”
Andy Stewart, CEO, Wilshire, said, “At its core, this transaction ensures both the investment solutions and index businesses continue to receive the resources they need to achieve long term success. This will enable us to seamlessly serve clients of both businesses and provide them the high quality services they rely on us for.”
John Ridding, CEO, Financial Times, said, “Almost two years ago, we announced our strategic collaboration with Mark and his team at Wilshire. We are excited to take this next step as a shareholder of the newly formed subsidiary. The FT has been a pioneer in digital journalism and the ‘new agenda’ for investing – including ESG, climate and technology. This collaboration will help us provide the data, metrics and indices to support market-leading analysis in traditional and new investment sectors, serving our readers even better and strengthening our position as the leading global financial news provider.”
Ng Kin Yee, Head of Data, Connectivity and Indices, SGX Group, added, “SGX welcomes the opportunity to partner with Wilshire Indexes, which is uniquely poised to gain adoption in a fast growing industry. Our partnership will offer institutional investors and intermediaries with more services built around best in class index designs.”
The company was advised by Solomon Partners and Kirkland & Ellis LLP.
About Wilshire
Wilshire is a global provider of market-leading indexes, advanced analytics, and multi-asset investment solutions. A trusted partner to a diverse range of more than 500 leading institutional investors and financial intermediaries, our clients rely on us to improve investment outcomes for a better future. Wilshire advises on over $1.3 trillion in assets and manages $83 billion in assets and is headquartered in the United States with offices worldwide.
About Wilshire Indexes
Wilshire Indexes is a global index provider offering more than 30 index series, including the market leading FT Wilshire 5000 and FT Wilshire Global Equity Markets indexes, as well as modular custom solutions tailored to meet the specific benchmarking needs of its customers.
Wilshire Indexes operates alongside Wilshire’s investment management and consulting, OCIO, alternatives and analytics businesses, which are separately known as Wilshire.
More information on Wilshire and Wilshire Indexes can be found at www.wilshire.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230327005255/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 14:00:00 CEST | Press release
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison
Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 13:45:00 CEST | Press release
Norwegian technology provider Cyviz has successfully developed a fully mobile and ballistic-proof command center - designed, configured, and made operational in just 24 hours. The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You do
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom